FDA.reportPublic FDA data

Nuplazid 34 MG Oral Capsule

RxCUI
2049278
RxNorm name
Nuplazid 34 MG Oral Capsule
Display name
Nuplazid 34 MG Oral Capsule
Full name
Nuplazid 34 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NUPLAZIDPIMAVANSERIN TARTRATEAcadia Pharmaceuticals Inc.1e6bea44-57d6-4bac-9328-46e1ee59f83b2026-06-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2049278

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1e6bea44-57d6-4bac-9328-46e1ee59f83bNUPLAZID 34 MG Oral Capsule [PSN] · pimavanserin 34 MG Oral Capsule [Nuplazid] [SBD] · Nuplazid 34 MG Oral Capsule [SY] · pimavanserin 34 mg (as pimavanserin tartrate 40 MG) Oral Capsule [Nuplazid] [SY]422These highlights do not include all the information needed to use NUPLAZID safely and effectively. See full prescribing information for NUPLAZID. NUPLAZID ® (pimavanserin) capsules, for oral use NUPLAZID ® (pimavanserin) tablets, for oral use Initial U.S. Approval: 201620260430